Monica Lanning, PA

Professional Titles

• Physician Assistant

Publications

• Addala A, Wong JJ, Penaranda RM, Hanes SJ, Abujaradeh H, Adams RN, Barley RC, Iturralde E, Lanning MS, Tanenbaum ML, Naranjo D, Hood KK. Expanding the use of patient-reported outcomes (PROs): Screening youth with type 1 diabetes from underrepresented populations. J Diabetes Complications. 2023 Jul;37(7):108514. PubMed PMID: 37263033
• Suttiratana SC, Wong JJ, Lanning MS, Dunlap A, Hanes SJ, Hood KK, Lal RA, Naranjo D. Qualitative Study of User Experiences with Loop, an Open-Source Automated Insulin Delivery System. Diabetes Technol Ther. 2022 Jun;24(6):416-423. PubMed PMID: 35099278
• Wong JJ, Suttiratana SC, Lal RA, Lum JW, Lanning MS, Dunlap A, Arbiter B, Hanes SJ, Bailey RJ, Hood KK, Naranjo D. Discontinued Use of the Loop Insulin Dosing System: A Mixed-Methods Investigation. Diabetes Technol Ther. 2022 Apr;24(4):241-248. PubMed PMID: 34780283
• Addala A, Suttiratana SC, Wong JJ, Lanning MS, Barnard KD, Weissberg-Benchell J, Laffel LM, Hood KK, Naranjo D. Cost considerations for adoption of diabetes technology are pervasive: A qualitative study of persons living with type 1 diabetes and their families. Diabet Med. 2021 Oct;38(10):e14575. PubMed PMID: 33794006
• Wong JJ, Hanes S, Iturralde E, Lanning MS, Naranjo D, Tanenbaum M, Hood KK. Do Youth Want Psychosocial Screenings in Diabetes Clinic? Profiles of Acceptability. J Pediatr Psychol. 2021 Mar 18;46(3):332-340. PubMed PMID: 33316061
• Lanning M, Shen J, Wasser D, Riddle S, Agustin B, Hood K, Naranjo D. Exposure to Closed Loop Barriers Using Virtual Reality. J Diabetes Sci Technol. 2020 Sep;14(5):837-843. PubMed PMID: 32019329
• Wong JJ, Barley RC, Hanes S, Tanenbaum ML, Lanning M, Naranjo D, Hood KK. Parental Perspectives: Identifying Profiles of Parental Attitudes and Barriers Related to Diabetes Device Use. Diabetes Technol Ther. 2020 Sep;22(9):674-680. PubMed PMID: 31971451
• Lanning MS, Tanenbaum ML, Wong JJ, Hood KK. Barriers to Continuous Glucose Monitoring in People With Type 1 Diabetes: Clinician Perspectives. Diabetes Spectr. 2020 Nov;33(4):324-330. PubMed PMID: 33223770
• Wong JJ, Addala A, Abujaradeh H, Adams RN, Barley RC, Hanes SJ, Iturralde E, Lanning MS, Naranjo D, Tanenbaum ML, Hood KK. Depression in context: Important considerations for youth with type 1 vs type 2 diabetes. Pediatr Diabetes. 2020 Feb;21(1):135-142. PubMed PMID: 31644828
• Tanenbaum ML, Adams RN, Lanning MS, Hanes SJ, Agustin BI, Naranjo D, Hood KK. Using Cluster Analysis to Understand Clinician Readiness to Promote Continuous Glucose Monitoring Adoption. J Diabetes Sci Technol. 2018 Nov;12(6):1108-1115. PubMed PMID: 29991281
• Lanning MS, Carmody D, Szczerbinski L, Letourneau LR, Naylor RN, Greeley SAW. Hypoglycemia in sulfonylurea-treated KCNJ11-neonatal diabetes: Mild-moderate symptomatic episodes occur infrequently but none involving unconsciousness or seizures. Pediatr Diabetes. 2018 May;19(3):393-397. PubMed PMID: 29205704
• Landmeier KA, Lanning M, Carmody D, Greeley SAW, Msall ME. ADHD, learning difficulties and sleep disturbances associated with KCNJ11-related neonatal diabetes. Pediatr Diabetes. 2017 Nov;18(7):518-523. PubMed PMID: 27555491
• Under review: DIA-2024-0481; Cardiovascular and Renal Biomarkers in Overweight and Obese Adults with Type 1 Diabetes Treated with Tirzepatide for 21 Months

Practice Locations

Specialty Information

• Endocrinology, Diabetes and Metabolism